EUVIMEDEUVIMED entdecken
Crossref

New Features in Screening of Retinopathy of Prematurity. Our Experience with New Recommendations for Retinopathy of Prematurity Screening

Dana Tomčíková, Zuzana Prepiaková, Beáta Bušányová, Barbora Kostolná

Czech and Slovak Ophthalmology · 30.05.2025

DOI: 10.31348/2025/23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Czech and Slovak Ophthalmology, online erschienen am 30.05.2025. Verfasst von Dana Tomčíková und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Neonatal Screening.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinopathy of prematurity (ROP) is always a serious and sight-threatening condition, and its treatable stages require early detection and adequate treatment. It is necessary to focus on the principles of screening of ROP and recurrences thereof, which occur more often with the onset of intravitreal treatment using anti-vascular endothelial growth factor (anti-VEGF) agents. In this study, we evaluate the recurrence of ROP after primary treatment with intravitreally administered bevacizumab or ranibizumab, its frequency and timing of occurrence. Also discussed are the rules for screening of ROP, its recurrence and the need for long-term follow-up monitoring of children with any form of ROP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinopathy of PrematurityNeonatal ScreeningHumansInfant, NewbornBevacizumabAngiogenesis InhibitorsRanibizumabIntravitreal InjectionsRecurrenceVascular Endothelial Growth Factor APractice Guidelines as Topic

Stichwörter der Autor:innen

ROP screeningROP recurrence screeningfollow-up monitoring of premature infants with ROPintravitreal treatment of ROPrecurrence of ROP

Substanzen

BevacizumabAngiogenesis InhibitorsRanibizumabVascular Endothelial Growth Factor A

Zitieren

APA

Tomčíková, D., Prepiaková, Z., Bušányová, B., & Kostolná, B. (2025). New Features in Screening of Retinopathy of Prematurity. Our Experience with New Recommendations for Retinopathy of Prematurity Screening. Czech and Slovak Ophthalmology. https://doi.org/10.31348/2025/23

Vancouver

Tomčíková D, Prepiaková Z, Bušányová B, Kostolná B. New Features in Screening of Retinopathy of Prematurity. Our Experience with New Recommendations for Retinopathy of Prematurity Screening. Czech and Slovak Ophthalmology. 2025. doi:10.31348/2025/23

BibTeX
@article{Tomkov2025,
  author = {Tomčíková, Dana and Prepiaková, Zuzana and Bušányová, Beáta and Kostolná, Barbora},
  title = {New Features in Screening of Retinopathy of Prematurity. Our Experience with New Recommendations for Retinopathy of Prematurity Screening},
  journal = {Czech and Slovak Ophthalmology},
  year = {2025},
  doi = {10.31348/2025/23}
}
Kostenlos starten →